DBVT · NASDAQ
DBV Technologies (DBVT) Stock Price & Fundamentals
DBV Technologies (DBVT) closed at $591.80 on Oct 9, 2026, up 0.12% from the previous close of $591.11.
Share price, past year
1Y +18.81%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $591.80 |
| Sep 30, 2026 | $581.06 |
| Aug 31, 2026 | $541.16 |
| Jul 31, 2026 | $530.71 |
| Jun 30, 2026 | $565.61 |
| May 29, 2026 | $574.09 |
| Apr 30, 2026 | $572.73 |
| Mar 31, 2026 | $528.68 |
| Feb 27, 2026 | $530.16 |
| Jan 30, 2026 | $539.50 |
| Dec 31, 2025 | $541.10 |
| Nov 28, 2025 | $500.97 |
| Oct 31, 2025 | $520.28 |
Key statistics
- Market cap
- $81.06B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.71
- Revenue (TTM)
- $4.94M
- Net income (TTM)
- −$175.95M
- Shares outstanding
- 137M
- Dividend yield
- —
- 52-week range
- $498.10 – $594.65
DBV Technologies's market cap is $81.06B, based on a share price of $591.80 and 137M shares outstanding as of Sep 30, 2025.
Financials
DBV Technologies reported revenue of $5.64M for fiscal 2025, up 35.77% from fiscal 2024.
DBV Technologies reported a net loss of $146.95M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $5.64M | +35.8% | −$146.95M | −2,607.3% | −$1.05 | −$121.71M |
| FY2024ended Dec 31, 2024 | $4.15M | −73.6% | −$113.92M | −2,744.4% | −$1.17 | −$106.81M |
| FY2023ended Dec 31, 2023 | $15.73M | +224.7% | $72.71M | 462.3% | −$0.76 | −$80.33M |
| FY2022ended Dec 31, 2022 | $4.84M | −15.1% | $96.27M | 1,987.5% | −$1.24 | −$56.42M |
| FY2021ended Dec 31, 2021 | $5.71M | −49.4% | −$97.81M | −1,713.5% | −$1.78 | −$109.15M |
| FY2020ended Dec 31, 2020 | $11.28M | −23.3% | −$159.56M | −1,415.0% | −$2.95 | −$168.40M |
| FY2019ended Dec 31, 2019 | $14.71M | — | −$172.01M | −1,169.5% | −$4.65 | −$153.91M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $700.00K | −$50.40M | −$0.12 |
| Q1 FY2026ended Mar 31, 2026 | $900.00K | −$47.60M | −$0.11 |
| Q4 FY2025ended Dec 31, 2025 | $562.00K | −$44.78M | −$0.24 |
| Q3 FY2025ended Sep 30, 2025 | $2.77M | −$33.16M | −$0.24 |
| Q2 FY2025ended Jun 30, 2025 | $1.50M | −$41.90M | −$0.31 |
| Q1 FY2025ended Mar 31, 2025 | $800.00K | −$27.10M | −$0.26 |
| Q4 FY2024ended Dec 31, 2024 | $511.00K | −$23.02M | −$0.23 |
| Q3 FY2024ended Sep 30, 2024 | $1.07M | −$30.44M | −$0.32 |
Company profile
- Name
- DBV Technologies S.A.
- Ticker
- DBVT
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 107 Avenue De La Republique, Chatillon
- Incorporated in
- I0
- Fiscal year ends
- December
- SEC CIK
- 0001613780
Recent SEC filings
- Sep 30, 2026
- Jul 16, 2026
- Jul 16, 2026
- Jun 29, 2026
- Jun 5, 2026
- Jun 3, 2026
- May 5, 2026
- Apr 30, 2026
Frequently asked questions
What is DBV Technologies's stock price?
DBV Technologies (DBVT) closed at $591.80 on Oct 9, 2026, up 0.12% from the previous close of $591.11.
What is DBV Technologies's market cap?
DBV Technologies's market cap is $81.06B, based on a share price of $591.80 and 137M shares outstanding as of Sep 30, 2025.
How much revenue does DBV Technologies make?
DBV Technologies reported revenue of $5.64M for fiscal 2025, up 35.77% from fiscal 2024.
Does DBV Technologies pay a dividend?
DBV Technologies's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from DBV Technologies S.A.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures